Back to Search
ANGELA WILLIAMS, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1215252267Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
41795(TX)
Research & Publications (20)
Topiramate reduces non-convulsive seizures after focal brain ischemia in the rat.
PMID 18063309·Neurosci Lett·2008
7-preclinical
Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat.
PMID 17605820·J Neuroinflammation·2007
4-observational
Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration.
PMID 17184192·J Neurotrauma·2006
7-preclinical
Severity level and injury track determine outcome following a penetrating ballistic-like brain injury in the rat.
PMID 17030434·Neurosci Lett·2006
4-observational
Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration.
PMID 16759750·Neurochem Int·2006
6-review
Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats.
PMID 16728590·J Pharmacol Exp Ther·2006
7-preclinical
Recovery from ischemic brain injury in the rat following a 10 h delayed injection with MLN519.
PMID 15894077·Pharmacol Biochem Behav·2005
4-observational
Characterization of a new rat model of penetrating ballistic brain injury.
PMID 15716636·J Neurotrauma·2005
7-preclinical
Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia.
PMID 15140918·J Pharmacol Exp Ther·2004
7-preclinical
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.
PMID 15060320·Stroke·2004
7-preclinical
Neuroprotection assessment by topographic electroencephalographic analysis: effects of a sodium channel blocker to reduce polymorphic delta activity following ischaemic brain injury in rats.
PMID 14703719·Fundam Clin Pharmacol·2003
4-observational
Treatment with the snail peptide CGX-1007 reduces DNA damage and alters gene expression of c-fos and bcl-2 following focal ischemic brain injury in rats.
PMID 12955387·Exp Brain Res·2003
7-preclinical
Central neuro-inflammatory gene response following soman exposure in the rat.
PMID 12951190·Neurosci Lett·2003
7-preclinical
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration.
PMID 12500093·J Cereb Blood Flow Metab·2003
7-preclinical
Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis.
PMID 12323394·Eur J Pharmacol·2002
7-preclinical
Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia.
PMID 11997694·Neuroreport·2002
7-preclinical
Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat.
PMID 11911860·Brain Res·2002
7-preclinical
Electroencephalogram analysis and neuroprotective profile of the N-acetylated-alpha-linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats.
PMID 11561062·J Pharmacol Exp Ther·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21106 KUYKENDAHL RD
SPRING, TX 77379 - Phone
- (281) 355-6325
Quick Facts
- NPI
- 1215252267
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile